Artemis overview
Artemis contact information
Offices
Contacts
| Name | Job title | Location | |
|---|---|---|---|
| Key Contact | Job titleChief Financial Officer and Chief Compliance Officer | LocationBoston, United States | Email |
| Key Contact | Job titlePartner and Chief Investment Officer | LocationBoston, United States | Email |
Job titleChief Operating Officer | LocationBoston, United States | Email | |
Job titleChief Financial Officer | LocationBoston, United States | Email | |
Artemis funds managed
Closed funds: 4
| Fund | Fund size | Close date | Strategy |
|---|---|---|---|
Fund size | Close dateSep 2026 | Strategy | |
Fund size | Close dateDec 2021 | Strategy | |
Fund size | Close dateJan 2019 | Strategy | |
Stories that mention Artemis
Continuation funds continue their streak: Story of the Year
In 2023, continuation funds spread to geographic markets anew and niche strategies such as impact funds, while increasingly involving complex situations and assets.
From hype to reality: continuation funds bear fruit for LPs
A recent continuation fund exit by TPG is further evidence that such vehicles can reward investors with the capacity and desire to roll over, or those who opt to back funds investing in these deals.
Bridgepoint sells life sciences company to KKR
The sale follows the firms’ divestment of pharmaceutical company Quotient also this month.
Bridgepoint picks up French med-tech company
The firm’s acquisition of Balt is the second through its Paris office this year as it continues to deploy its €4bn fifth fund.
Bridgepoint books 2.9x on cruise operator
The sale comes as the pan-European firm continues to deploy its €4bn Bridgepoint Europe V, which reached its hard cap earlier this year.
Friday Letter Suited to life in public
Jon Moulton’s Better Capital is doing what most listed private equity funds can only dream of: trading at a premium.
Buyout pair mulls options after £5.2bn ISS sale collapse
EQT and Goldman’s sale of Danish services group ISS has collapsed after shareholders in G4S, the acquirer, vetoed the £5.2bn deal.
Suited to life in public
Jon Moulton’s Better Capital is doing what most listed private equity funds can only dream of: trading at a premium.